Sandoz stock: Goldman Sachs raises target to CHF 85.00
Published on 10/23/2026 at 16:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSGoldman Sachs target raised
- Goldman Sachs lifted its Sandoz target to CHF 85.00 from CHF 80.00 on October 8, 2026.
- Sandoz trades 0.77 percent below its CHF 80.24 52-week high as of October 23, 2026.
- Sandoz stock costs EUR 86.44 at Lang & Schwarz on October 23, 2026 at 4:37 p.m. CEST, 0.65 percent above the Xetra close.
- Sandoz is scheduled to release third-quarter sales on October 27, 2026.
Sandoz (CH1243598427) has a Goldman Sachs target of CHF 85.00, raised from CHF 80.00 on October 8, 2026, according to Cash. At the SIX price of CHF 79.62 on October 23, 2026 at 4:32 p.m. CEST, that target stood 6.76 percent above the share price. Sandoz was trading at EUR 86.44 at Lang & Schwarz on October 23, 2026 at 4:37 p.m. CEST, up 0.65 percent versus the Xetra close of October 22, 2026 at EUR 85.88.
Goldman target points to CHF 85.00
Goldman Sachs kept its Buy rating while lifting the target by CHF 5.00. The same report projected third-quarter currency-adjusted revenue growth of 6.10 percent, with biosimilar sales rising 20.60 percent and generics declining 0.30 percent. Those figures are forecasts, not reported results, and the report also identified generic-drug pricing pressure as an issue for the fourth quarter and 2027.
CHF 80.24 high sets the frame
Sandoz traded between CHF 48.15 and CHF 80.24 over the 52 weeks to October 23, 2026. The SIX price of CHF 79.62 was therefore 0.77 percent below the high and 65.43 percent above the low. The stock had gained 36.58 percent since the start of 2026, while its market capitalization stood at CHF 34.5 billion and its price-to-earnings ratio was 64.85 on October 23, 2026.
What does CHF 85.00 imply?
The Goldman Sachs target is CHF 5.38 above the October 23 SIX price, a 6.76 percent difference. A counterweight came from AlphaValue/Baader Europe, which cut its rating to Reduce on October 19, 2026, as reported by MarketScreener.
October 27 sales update
Sandoz is scheduled to publish its third-quarter sales and revenue update on October 27, 2026, according to MarketScreener. The company had reiterated full-year 2026 guidance in an October 1, 2026 pre-close brief, calling for mid-to-high single-digit constant-currency sales growth and a core EBITDA margin expansion of 100 basis points, according to VermoegensZentrum.
Price remains close to the high
Sandoz was trading at EUR 86.44 at Lang & Schwarz on October 23, 2026 at 4:37 p.m. CEST, 0.65 percent above the Xetra close of October 22, 2026 at EUR 85.88. The further course of trading is shown by the continuously updated real-time quote of Sandoz stock.
Sandoz stock facts
- Company: Sandoz Group AG
- ISIN: CH1243598427
- Ticker: SDZ
- Primary exchange: SIX
- Price Lang & Schwarz (as of October 23, 2026, 4:37 p.m. CEST): EUR 86.44
- Change versus Xetra close: plus 0.65 percent
- Xetra close (October 22, 2026): EUR 85.88
- Market capitalization: CHF 34.5 billion (as of October 23, 2026)
- 52-week range: CHF 48.15-80.24 (as of October 23, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - Specialty and Generic
- Index membership: SMI
Market context: Market report SMI.
